3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain

被引：16
|
作者：
Yasojima, K [1 ]
McGeer, EG [1 ]
McGeer, PL [1 ]
机构：
[1] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada
来源：
NEUROREPORT | 2001年 / 12卷 / 13期
关键词：
ApoE; cholesterol synthesis; heart; kidney; liver; spleen; statins;
D O I：
10.1097/00001756-200109170-00036
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Statins are widely used pharmaceutical agents which lower plasma cholesterol by inhibiting the rate controlling enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase. One epidemiological study suggests that statin therapy may provide protection against Alzheimer disease (AD). The aim of the present study was to determine the relative expression of HMG-CoA reductase nnRNAs in various areas of brain as well as in peripheral organs and to compare values in AD and control cases. High levels of the mRNA were found in all areas of brain but no obvious differences were found between AD and controls. We conclude that brain has a robust capacity to synthesize cholesterol which appears to be unaffected by AD pathology. NeuroReport 12:2935-2938 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码：2935 / 2938
页数：4
相关论文
共 50 条
  • [1] Stereoselective synthesis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
    Wu, Yan
    Xiong, Fang-Jun
    Chen, Fen-Er
    TETRAHEDRON, 2015, 71 (45) : 8487 - 8510
  • [2] Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
    van Besien, Herman
    Sassano, Antonella
    Altman, Jessica K.
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2013, 54 (12) : 2601 - 2605
  • [3] Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review
    Pfefferkorn, Jeffrey A.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (02) : 187 - 203
  • [4] Pleiotrophic effects of statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors)
    Igel, M
    Sudhop, T
    von Bergmann, K
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2003, 53 (08): : 545 - 553
  • [5] Anticancer auranofin engages 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) as a target
    Tian, Songhai
    Siu, Fung-Ming
    Lok, Chun-Nam
    Fung, Yi Man Eva
    Che, Chi-Ming
    METALLOMICS, 2019, 11 (11) : 1925 - 1936
  • [6] Optimization, Validation and Application of Spectrophotometric Assay for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Activity
    Liang, Gai
    Kou, Hao
    Wang, Ting-ting
    Guo, Yu
    Ping, Jie
    Wang, Hui
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (04) : 671 - 677
  • [7] Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)
    Arefieva, T. I.
    Filatova, A. Yu.
    Potekhina, A. V.
    Shchinova, A. M.
    BIOCHEMISTRY-MOSCOW, 2018, 83 (08) : 874 - 889
  • [8] Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)
    T. I. Arefieva
    A. Yu. Filatova
    A. V. Potekhina
    A. M. Shchinova
    Biochemistry (Moscow), 2018, 83 : 874 - 889
  • [9] Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase increases the expression of interferon-responsive genes
    Yang, Xin
    Ouyang, Hongsheng
    Chen, Fuwang
    Ma, Teng
    Dong, Meichen
    Wang, Fei
    Pang, Daxing
    Peng, Zhiyuan
    Ren, Linzhu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (12) : 950 - 955
  • [10] 3-Hydroxy-3-methylglutaryl-coenzyme A reductase modulator: toward age-and sex-personalized medicine
    Pallottini, Valentina
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (10) : 1079 - 1083
12345